UK356618 is a potent and selective inhibitor of matrix metalloproteinase-3 (MMP-3) with an IC50 of 5.9 nM; it shows significantly reduced inhibitory activity against MMP-1, MMP-2, MMP-9, MMP-13, and MMP-14; it effectively abolishes TNF-α-induced cell migration in NCI-H446 lung cancer cells; in vivo, it significantly reduces MMP-3 activity in the brain following intravenous administration (15 mg/kg) in hyperglycemic male Wistar rats subjected to middle cerebral artery occlusion (MCAO).